International Parkinson and Movement Disorder Society®

MDS wishes to acknowledge the following Marquee Level supporters of the 2025 International Congress: Roche and Theravance Biopharma US. #MDSCongress

MDS wishes to acknowledge the following Bronze Level supporters of the 2025 International Congress: Amprion Inc., Association of Movement Disorder Advanced Practice Providers, BlueRock Therapeutics LP, Cala Health, Capsida Biotherapeutics, and ClearSky Medical Diagostics #MDSCongress

MDS wishes to acknowledge the following Silver Level supporters of the 2025 International Congress: Abbott, Britannia Pharmaceuticals Ltd., Emalex Biosciences, Insightec, Ipsen Biopharmaceuticals, Inc., and Teva Pharmaceuticals. #MDSCongress

MDS wishes to acknowledge the following Gold Level supporters of the 2025 International Congress: Boston Scientific and PTC Therapeutics. #MDSCongress

MDS wishes to acknowledge the following Platinum Level supporters of the 2025 International Congress: Acadia Pharmaceuticals Inc., AskBio Inc., Biogen, H Lundbeck A/S, Medtronic, Merz Theraputics GmbH, and Supernus Pharmaceuticals. #MDSCongress

MDS wishes to acknowledge the following Diamond Level supporters of the 2025 International Congress: Amneal Pharmaceuticals and Abbvie. #MDSCongress

Gain essential skills for both clinical practice and research: emerging therapies, advanced techniques, and refined diagnostic strategies that integrate test analysis with thorough clinical evaluation. https://loom.ly/2EcHutA

The definition and classification of the dystonias: A new consensus report Updates include additional clinical features, clarifications, emphasis on the extensive underlying biological heterogeneity across subtypes.

New consensus report on dystonia: Updated definition & classification with added clinical features, clarifications, and emphasis on biological heterogeneity. https://loom.ly/-jglkDU

#MDSCongress experts will review the most impactful recent publications in both clinical and basic neuroscience. Mdscongress.org

Deep learning-based artificial intelligence algorithm to classify tremors from hand-drawn spirals Study affirms that hand-drawn spirals contain quantifiable features that can be leveraged by DL models.

New study shows deep learning can classify tremors from hand-drawn spirals. https://loom.ly/xRbdldE

Moving Along 2025, issue 3 40 years of MDS: A look back through the newsletter

New Moving Along issue: 40 years of MDS, dystonia classification, MDSgene updates, and more.
Read all the latest: https://loom.ly/tHQICZU

Did you know Movement Disorders the first-ever video journal? Discover how this innovation helped establish consensus, and the field itself.

Join us at the #MDSCongress as we celebrate the past and build the future. Mdscongress.org

Junior Awardee Dr. Jung Hwan Shin discusses his journey through movement disorders and what led him to study specific neuronal sub-types within the STN. He shares his future hopes for DBS treatments and how he believes his research may contribute. https://loom.ly/2xVAI74

Junior Awardee Dr. Lydia Chougar discusses her work combining neuroimaging with transcriptomics and PET maps to uncover the biological underpinnings of structural abnormalities in multiple system atrophy. https://loom.ly/SaQGrvM

Gain the specialty skills to recognize hallmark clinical features, uncover diagnostic clues, and manage a variety of patients. https://loom.ly/NdaHSqA

2025 #MDSCongress controversy debates: Learn how to make a more informed choice when sharing research results with patients and how a biologically-based definition of PD may or may not accelerate therapeutic discovery. Mdscongress.org

Visual examples are incredibly helpful for learning the different functional movement disorders and their mechanisms. This course uses patient videos to demonstrate how clinicians evaluate often-tricky diagnoses. https://loom.ly/axmgg-4

Celebrating 40 Years of MDS — and the Women Who Paved the Way

As we reflect on the history of MDS, we honor the extraordinary women who shaped not only our science but our community. Join us to celebrate 40 years of MDS at the #MDSCongress. Mdscongress.org

Infection can be the cause of any of the most prevalent movement disorder phenotypes (as shown). A survey of clinicians by the MDS IRMD Study Group indicated that knowledge of the more well-established associations prominently contributes to diagnosis. https://loom.ly/QaddO5I

Dr. Cecilia Tremblay discusses her recent study, which is this year's MDCP Research Article of the Year, highlighting the potential accuracy of hyposmia and RBD in predicting Lewy pathology. https://loom.ly/x-625g4

Dr. Charulata Sankhla discusses the main findings of this year's MDCP Review Article of the Year, which covers the current status and diagnosis of subacute sclerosing panencephalitis (SSPE). https://loom.ly/uafZc2g

Attend the Video Challenge, MDS’s most popular event, at the #MDSCongress. Register today. mdscongress.org

MDS-0725-434: MDS Education Needs Assessment 2026 Take this survey powered by surveymonkey.com. Create your own surveys for free.

MDS is planning for 2026, and your feedback is important. Help guide the future of our educational offerings. https://loom.ly/qSx50w8

International collaboration has helped advance our understanding of movement disorders. Learn about global successes and strategies to address current gaps in global access to research and care. Mdscongress.org

This year’s #mdscongress theme celebrates the future of disease-modifying therapies and the many areas of investigation designated to achieving this goal within the field of PD.

A global review conducted by MDS’s PSP Study Group attributed regional variations in prevalence and phenotype to differences in genetics, environmental risk, and healthcare infrastructure. Increased adoption of updated MDS-PSP criteria has improved diagnostic accuracy. https://loom.ly/b0CHSos

PD non-motor symptoms can be classified in 3 ways: autonomic, psychiatric/cognition, and sleep. Treating these symptoms is complex and differs between patients. Learn how multidisciplinary teams can further help PD patients. https://loom.ly/DsWX7_A

The 2025 C. David Marsden awardee, Dr. Jon Stoessl, discusses his contributions to the movement disorder field, the evolution of neuroimaging, and lessons he hopes to pass on to more junior colleagues. https://loom.ly/CvWVvuo

The 2025 Staney Fahn awardee, Prof. Mark Edwards, discusses his musings on interface disorders, such as FNDs, and what changes he believes need to take place in modern medicine to better treat these patients. https://loom.ly/izciuoE

Learn to take decisive action during emergencies, when every moment matters. https://loom.ly/toJc2VE